CN105617396B - 一种加兰他敏经鼻给药纳米脑靶向药物及其制备方法 - Google Patents
一种加兰他敏经鼻给药纳米脑靶向药物及其制备方法 Download PDFInfo
- Publication number
- CN105617396B CN105617396B CN201610071476.3A CN201610071476A CN105617396B CN 105617396 B CN105617396 B CN 105617396B CN 201610071476 A CN201610071476 A CN 201610071476A CN 105617396 B CN105617396 B CN 105617396B
- Authority
- CN
- China
- Prior art keywords
- chitosan
- galanthamine
- brain
- targeted drug
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
脑组织 | 加兰他敏原药 | 加兰他敏新型药物 |
嗅球 | 1.1 | 36.0 |
嗅束 | 1.0 | 16.2 |
大脑 | 1.1 | 26.2 |
小脑 | 1.2 | 25.6 |
样品 | 抑制率(%)±S.D. |
0.1mg/ml | 27±3 |
0.5mg/ml | 54±2 |
1.0mg/ml | 89±4 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610071476.3A CN105617396B (zh) | 2016-02-01 | 2016-02-01 | 一种加兰他敏经鼻给药纳米脑靶向药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610071476.3A CN105617396B (zh) | 2016-02-01 | 2016-02-01 | 一种加兰他敏经鼻给药纳米脑靶向药物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105617396A CN105617396A (zh) | 2016-06-01 |
CN105617396B true CN105617396B (zh) | 2020-01-17 |
Family
ID=56032990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610071476.3A Active CN105617396B (zh) | 2016-02-01 | 2016-02-01 | 一种加兰他敏经鼻给药纳米脑靶向药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105617396B (zh) |
-
2016
- 2016-02-01 CN CN201610071476.3A patent/CN105617396B/zh active Active
Non-Patent Citations (4)
Title |
---|
"Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer’s disease management: preparation and detection in rat brain";Amira S. Hanafy et al.;《Drug Development and Industrial Pharmacy》;20150702;第41卷(第12期);第2055-2068页 * |
"壳聚糖-丝裂霉素缀合物的制备及体外释放";段丽红等;《高分子材料科学与工程》;20130831;第29卷(第8期);第174-177,181页 * |
"壳聚糖-聚乙烯亚胺基因载体的制备";段丽红等;《高分子材料科学与工程》;20110731;第27卷(第7期);第155-158页 * |
"醛类氧化为羧酸的简法";Babu BR et al.;《中国医药工业杂志》;19941231(第10期);第436页 * |
Also Published As
Publication number | Publication date |
---|---|
CN105617396A (zh) | 2016-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107684559B (zh) | 一种含金团簇的物质及其制备方法与应用 | |
Zhang et al. | Generation-6 hydroxyl PAMAM dendrimers improve CNS penetration from intravenous administration in a large animal brain injury model | |
Xu et al. | pH/ROS dual-sensitive and chondroitin sulfate wrapped poly (β-amino ester)-SA-PAPE copolymer nanoparticles for macrophage-targeted oral therapy for ulcerative colitis | |
Qi et al. | Electrospun fibers of acid-labile biodegradable polymers containing ortho ester groups for controlled release of paracetamol | |
WO2018157874A1 (zh) | 一种双氢青蒿素二倍体衍生物、其药物组合物及应用 | |
Don et al. | Curcumin-laden dual-targeting fucoidan/chitosan nanocarriers for inhibiting brain inflammation via intranasal delivery | |
US20090324741A1 (en) | Injectable polymer-lipid blend | |
WO2020143662A1 (zh) | 一种壳寡糖修饰的自携式无载体鼻腔纳米制剂脑靶向递送系统及其制备方法 | |
CN115607523A (zh) | 用于缓解和/或治疗阿尔兹海默症的组合物及其制备方法、应用 | |
Zhu et al. | C-176 loaded Ce DNase nanoparticles synergistically inhibit the cGAS-STING pathway for ischemic stroke treatment | |
Niu et al. | Hyaluronic acid micelles for promoting the skin permeation and deposition of curcumin | |
US20170027977A1 (en) | Methods useful in the prevention of hypoxic injury | |
CN102379850B (zh) | 一种穿越人体粘液屏障的靶向给药脂质体 | |
CN105617396B (zh) | 一种加兰他敏经鼻给药纳米脑靶向药物及其制备方法 | |
KR20090080046A (ko) | pH 표적화된 약물 운반용 조성물 및 방법 | |
CN109731105B (zh) | 一种用于防治早期神经退行性疾病的鼻腔纳米自噬诱导剂及其制备方法 | |
CN105582545B (zh) | 一种力可拉敏经鼻给药纳米脑靶向药物及其制备方法 | |
Shiri et al. | Novel and green synthesis of a nanopolymer and its use as a drug delivery system of silibinin and silymarin extracts in the olfactory ensheathing cells of rats in normal and high-glucose conditions | |
CN109528719B (zh) | 长春西汀在制备预防和/或治疗急进高原导致的高原病的药物中的应用 | |
Zhao et al. | Evaluation of the efficacy, biocompatibility, and permeation of bupivacaine-loaded poly (epsilon-caprolactone) nano-capsules as an anesthetic | |
CN105617395B (zh) | 一种经鼻给药脑靶向纳米载药体系的制备方法 | |
He et al. | A Gel/fiber composite formulation achieves sequential delivery based on multimodal analgesia reducing chronic pain | |
CN117442582A (zh) | 一种肾小球靶向的ros响应性阳离子聚合物纳米颗粒药物组合物及其制备方法和应用 | |
US20240131182A1 (en) | Gold clusters, compositions, and methods for treatment of depression | |
US20240226323A9 (en) | Gold clusters, compositions, and methods for treatment of depression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20191202 Address after: 518028 No. 2008, Sungang West Road, Futian District, Shenzhen City, Guangdong Province Applicant after: Shenzhen Institute of Gerontology Applicant after: Wu Zhengzhi Address before: 518020 No. 3 Dongmen North Road, Shenzhen, Guangdong, Luohu District Applicant before: Shenzhen Institute of Gerontology |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210908 Address after: 518107 1301, building 1, hengtaiyu building, Tangwei community, Fenghuang street, Guangming District, Shenzhen, Guangdong Patentee after: Shenzhen Jintai pharmaceutical technology partnership (L.P.) Patentee after: Wu Zhengzhi Address before: No. 2008, Sungang West Road, Futian District, Shenzhen, Guangdong 518028 Patentee before: SHENZHEN INSTITUTE OF GERIATRICS Patentee before: Wu Zhengzhi |
|
TR01 | Transfer of patent right |